From awareness to action: Advancing menopause policy for a competitive and equal Europe

Menopause is a universal life stage, yet it remains largely invisible in policy debates—despite its far-reaching implications for health systems, labour markets, and gender equality. In the EU, rising life expectancy and rapid population ageing mean that more women will spend decades post-menopause, at a time when Europe is also grappling with workforce shortages and competitiveness challenges. By 2030, an estimated 51.9 million women in Europe will be experiencing menopause, making it an increasingly urgent policy issue. 

Despite its scale, menopause remains largely absent from EU strategies and workplace norms. Stigma and limited support can delay diagnosis and undermine women’s health and participation at work—driving absenteeism, reduced productivity, and early exit from the labour market, often referred to as the “menopause penalty.” The economic impact is significant: in Germany alone, workplace disruptions linked to unmanaged symptoms are estimated to cost companies EUR 9.5 billion annually. At the same time, access to care and treatment varies across Member States, alongside persistent gaps in training, data, and research. 

As the EU shapes its 2026–2030 Gender Equality Strategy and broader women’s health agenda, there is a clear opportunity to embed menopause as a cross-cutting priority—linking health, employment, and equality, and contributing to closing the “Women’s Health Gap.” 

This policymakers’ breakfast will convene EU decision-makers, experts, and stakeholders to turn awareness into concrete action—focusing on access to care, research gaps, workplace support, and integration into key EU frameworks, including the European Health Union and Gender Equality Strategy. 


Interested in this event?

Event Details

Main guiding questions include but are not limited to:

- How can menopause be effectively integrated into EU health, employment, and gender equality policies, including the upcoming Gender Equality Strategy?
- How can the EU move beyond basic workplace accommodations to tackle the 'Menopause Penalty', ensuring that menopausal health does not act as a final glass ceiling for women reaching senior leadership and decision-making roles?
- In the context of the European Health Union, how can we bridge the gap between clinical care and workplace reality—specifically by training healthcare providers in 'occupational menopause' and incentivizing employers to adopt EU-wide health standards?
- What actions are needed to close the gaps in awareness, data, and research on menopause, and how can stakeholders collaborate to drive evidence-based policymaking?
- With the Gender Equality Strategy 2026–2030 now unveiled, what specific benchmarks or 'Women's Health Indicators' should the Commission adopt to monitor Member State progress in menopause care and workplace support?

Director for Equality and Non Discrimination in DG Justice and Consumers
European Commission
SVP, Global Head of Public Affairs, Sustainability & Internal Engagement
Bayer
MEP (S&D, Croatia)
European Parliament
(S&D, Portugal)
European Parliament
Event Details
    Sponsors